National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
eculizumab (ek-yoo-LY-zoo-mab)

 A monoclonal antibody used to prevent red blood cells from being destroyed in patients with paroxysmal nocturnal hemoglobinuria (PNH), a red blood cell disorder. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body. Eculizumab blocks a protein in the blood that causes the breakdown of red blood cells. Also called Soliris.

Previous Definitions:echocardiography, ECT, ecteinascidin 743, ectocervical, ectomesenchymoma
Next Definitions:eczema, edatrexate, edema, edotecarin, edrecolomab